Abbott Laboratories

lobbying client · lobbying firm

Abbott Laboratories's federal footprint — reported lobbying spend and, where matched, federal money received. Figures are as reported to the U.S. Senate (LDA) and USAspending.

Lobbying from Senate LDA

Reported lobbying (spent)$28,202,496

Years coveredFY2022–FY2025

Reported lobbying billed / handled $23,152,496

Firm activeFY2022–FY2025

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Abbott Laboratories per filing year
FY	Lobbying spend (as client)	Lobbying billed / handled (as firm)
2022	$9,400,000	$8,140,000
2023	$6,140,000	$4,930,000
2024	$6,690,000	$5,490,000
2025	$5,972,496	$4,592,496

Two figures: what Abbott Laboratories reported spending on its own lobbying (as a client) and what it billed or handled for the clients it represents (as a firm — revenue, not its own spend). For a self-filer these overlap.

Firms hired

Akin Gump Strauss Hauer & Feld $1,020,000 · 17 filings
Kountoupes Denham Carr & Reid, LLC $960,000 · 16 filings
W Strategies, LLC $800,000 · 16 filings
Thegroup Dc, LLC $720,000 · 12 filings
Impact Health Policy Partners $480,000 · 12 filings
Bgr Government Affairs $370,000 · 13 filings
S-3 Group $240,000 · 4 filings
Marshall & Popp, LLC $240,000 · 4 filings
Tiber Creek Group $200,000 · 4 filings
Mayer Brown LLP $20,000 · 2 filings

Registrants that filed lobbying on behalf of Abbott Laboratories.

Clients represented

Self-filed — Abbott Laboratories registers and lobbies on its own behalf, with no separate outside clients.

Issues

Issue area	Lobbied	Worked
Health Issues	114	22
Taxation/Internal Revenue Code	83	20
Agriculture	30	20
Food Industry (safety, labeling, etc.)	30	11
Medicare/Medicaid	28	22
Trade (domestic/foreign)	25	22
Medical/Disease Research/Clinical Labs	12	—
Veterans	11	11
Pharmacy	9	—
Budget/Appropriations	7	1
Law Enforcement/Crime/Criminal Justice	7	7
Consumer Issues/Safety/Products	3	3
Transportation	3	3
Copyright/Patent/Trademark	1	—
Foreign Relations	1	—
Tariff (miscellaneous tariff bills)	1	1

Issue areas across Abbott Laboratories's filings, by activity count — as the client (Lobbied) and as the registrant/firm (Worked). Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

FY2025 Health Issues as client

Issues related to global health policy and funding.
FY2025 Budget/Appropriations as client

Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026.

H.R. 4779
FY2025 Health Issues as client

Issues related to infant formula.
FY2025 Trade (domestic/foreign) as client

Issues related to infant formula.
FY2025 Taxation/Internal Revenue Code as client

Issues related to infant formula.
FY2025 Agriculture as client

Issues related to infant formula.
FY2025 Budget/Appropriations as client

Issues related to infant formula.
FY2025 Health Issues as client

Issues related to global health policy and funding.

Show 52 more activities

FY2025 Budget/Appropriations as client

Issues related to global health policy and funding.
FY2025 Agriculture as client

Issues related to infant formula.
FY2025 Medicare/Medicaid self-filed

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

S. 1000 H.R. 1835
FY2025 Trade (domestic/foreign) self-filed

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.
FY2025 Agriculture self-filed

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals regarding the implementation and modernization of the WIC Program.

H.R. 2300
FY2025 Taxation/Internal Revenue Code self-filed

Proposals to reform domestic and international tax structures.
FY2025 Health Issues self-filed

S. 2426 Equitable Community Access to Pharmacist Services Act. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

S. 2426
FY2025 Agriculture as client

Issues related to infant formula
FY2025 Medicare/Medicaid as client

Equitable Access to Community Pharmacist Services Act
FY2025 Health Issues as client

Equitable Access to Community Pharmacist Services Act
FY2025 Taxation/Internal Revenue Code as client

Proposals to reform domestic and international tax structures
FY2025 Health Issues as client

Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula
FY2025 Medicare/Medicaid as client

Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula
FY2025 Agriculture as client

Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula
FY2025 Taxation/Internal Revenue Code as client

Equitable Access to Community Pharmacist Services Act; proposals to reform domestic and international tax structures; infant formula
FY2025 Health Issues as client

Issues related to global health policy and funding.
FY2025 Budget/Appropriations as client

Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026.

H.R. 4779
FY2025 Agriculture as client

Issues related to infant formula
FY2025 Medicare/Medicaid as client

Equitable Access to Community Pharmacist Services Act
FY2025 Health Issues as client

Equitable Access to Community Pharmacist Services Act
FY2025 Taxation/Internal Revenue Code as client

Proposals to reform domestic and international tax structures
FY2025 Medicare/Medicaid as client

Equitable Access to Community Pharmacist Services Act
FY2025 Health Issues as client

Equitable Access to Community Pharmacist Services Act
FY2025 Taxation/Internal Revenue Code as client

Proposals to reform domestic and international tax structures
FY2025 Agriculture as client

Issues related to infant formula
FY2025 Health Issues self-filed

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to medical device cybersecurity. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

S. 2477 H.R. 1770
FY2025 Medicare/Medicaid self-filed

Proposals related to Medicare coverage of continuous glucose monitors.
FY2025 Trade (domestic/foreign) self-filed

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains.
FY2025 Agriculture self-filed

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

H.R. 2300
FY2025 Taxation/Internal Revenue Code self-filed

Proposals to reform domestic and international tax structures.
FY2025 Food Industry (safety, labeling, etc.) self-filed

S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024.

S. 3387 H.R. 9817
FY2025 Trade (domestic/foreign) as client

Issues related to U.S.-U.K. trade relations and supply chains.
FY2025 Taxation/Internal Revenue Code as client

Issues related to OECD tax negotiations.
FY2025 Health Issues as client

Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

H.R. 2300
FY2025 Food Industry (safety, labeling, etc.) as client

Issues related to the supply of infant formula and nutrition.
FY2025 Taxation/Internal Revenue Code as client

Issues related to corporate taxation.
FY2025 Health Issues as client

Issues related to cardiovascular health. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

H.R. 3164 S. 2426
FY2025 Health Issues as client

Global health policy and funding.
FY2025 Foreign Relations as client

Global health policy and funding.
FY2025 Budget/Appropriations as client

Global health policy and funding.
FY2025 Food Industry (safety, labeling, etc.) as client

Issues related to the supply of Infant Formula.
FY2025 Health Issues as client

Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

H.R. 2300
FY2025 Health Issues self-filed

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to telehealth implementation and remote monitoring. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

S. 2477 H.R. 1770
FY2025 Medicare/Medicaid self-filed

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

S. 1000 H.R. 1835
FY2025 Trade (domestic/foreign) self-filed

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.
FY2025 Agriculture self-filed

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

H.R. 2300
FY2025 Taxation/Internal Revenue Code self-filed

Proposals to reform domestic and international tax structures.
FY2025 Food Industry (safety, labeling, etc.) self-filed

S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023.

S. 3387
FY2025 Taxation/Internal Revenue Code as client

OECD tax negotiations.
FY2025 Food Industry (safety, labeling, etc.) as client

Issues related to the supply of infant formula and nutrition.
FY2025 Taxation/Internal Revenue Code as client

Issues related to corporate taxation.
FY2025 Health Issues as client

Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to medical device reimbursement.

H.R. 3164 S. 2426

The specific issues and bills Abbott Laboratories reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.